Core Viewpoint - The company Baolidi expects a net profit of 145 million to 152 million yuan for the fiscal year 2025, representing a year-on-year growth of 27.17% to 33.30% [1] Group 1: Financial Performance - The company has strengthened its R&D innovation and market expansion, leading to an optimization of product structure and market penetration, resulting in both sales and quality improvements [1] - Revenue growth has been steady, driven by enhanced cost control and lean management, which have improved the product gross margin and led to a year-on-year increase in total gross profit [1] - The share-based payment expenses from the previous equity incentive plan have significantly decreased compared to the same period last year, providing positive support for profit growth [1] Group 2: Management Information - Xu Yiming, the chairman and legal representative of the company, has a background in various technical and managerial roles within the industry, having served as chairman and general manager of Baolidi Plastics from 2002 to 2018 [2] - Xu Yiming's salary for 2024 is reported to be 1.02 million yuan [3]

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

报告期内，公司持续强化研发创新与市场拓展，推动产品结构优化及市场渗透，实现销量与品质双升， 驱动营业收入保持稳健增长。通过深化成本管控与精益管理，产品毛利率持续改善，带动毛利总额同比 增长。此外，前期实施的股权激励计划进入费用摊销后期，本期股份支付费用较去年同期大幅减少，对 利润增长形成正向支撑。综上，公司经营业绩延续良好增长态势。报告期内，公司非经常性损益对上市 公司归母净利润的影响金额约400万元。 格隆汇1月8日丨宝丽迪(300905.SZ)公布，预计2025年归属于上市公司股东的净利润14500万元–15200万 元，比上年同期增长27.17%-33.30%，扣除非经常性损益后的净利润14100万元–14800万元，比上年同期 增长36.59%-43.37%。 ...

智通财经APP讯，宝丽迪(300905.SZ)披露2025年年度业绩预告，公司预计归属于上市公司股东的净利润 1.45亿元至1.52亿元，同比增长27.17%至33.30%;扣除非经常性损益后的净利润1.41亿元至1.48亿元，同 比增长36.59%至43.37%。 ...

格隆汇1月8日丨宝丽迪(300905.SZ)公布，预计2025年归属于上市公司股东的净利润14500万元–15200万 元，比上年同期增长27.17%-33.30%，扣除非经常性损益后的净利润14100万元–14800万元，比上年同期 增长36.59%-43.37%。 报告期内，公司持续强化研发创新与市场拓展，推动产品结构优化及市场渗透，实现销量与品质双升， 驱动营业收入保持稳健增长。通过深化成本管控与精益管理，产品毛利率持续改善，带动毛利总额同比 增长。此外，前期实施的股权激励计划进入费用摊销后期，本期股份支付费用较去年同期大幅减少，对 利润增长形成正向支撑。综上，公司经营业绩延续良好增长态势。报告期内，公司非经常性损益对上市 公司归母净利润的影响金额约400万元。 ...

Core Viewpoint - The company expects a net profit attributable to shareholders of 145 million to 152 million yuan for the fiscal year 2025, representing a year-on-year growth of 27.17% to 33.30% [1] Financial Performance - The company has strengthened research and development innovation and market expansion, optimizing product structure to drive both sales and quality improvements [1] - Operating revenue has shown steady growth, while gross profit margin continues to improve, with total gross profit increasing year-on-year [1] - Significant reduction in share-based payment expenses compared to the same period last year has positively impacted profit growth [1]

每经AI快讯，1月8日，宝丽迪(300905.SZ)发布2025年度业绩预告，预计归属于上市公司股东的净利润 为1.45亿元~1.52亿元，比上年同期增长27.17%~33.30%。报告期内，公司强化研发创新与市场拓展，优 化产品结构，推动销量与品质双升，营业收入稳步增长；深化成本管控与精益管理，毛利率持续改善， 毛利总额同比增长；同时股份支付费用较去年同期大幅减少，利好利润增长。 ...

Core Viewpoint - The company, Baolidi, expects a net profit of 145 million to 152 million yuan for the fiscal year 2025, representing a year-on-year growth of 27.17% to 33.30% [1] Group 1: Financial Performance - The company is focusing on enhancing research and development innovation and market expansion, which has led to an optimization of product structure and market penetration [1] - Sales volume and product quality have both improved, driving steady growth in operating revenue [1] - The gross profit margin has continuously improved due to deepened cost control and lean management, resulting in a year-on-year increase in total gross profit [1] Group 2: Cost Management and Incentives - The implementation of the equity incentive plan has entered the later stage of expense amortization, significantly reducing share-based payment expenses compared to the same period last year, positively supporting profit growth [1]

证券代码：300905 证券简称：宝丽迪 公告编号：2026-001 苏州宝丽迪材料科技股份有限公司 2025年年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 (一) 业绩预告期间 2025 年 1 月 1 日— 2025 年 12 月 31 日。 (二) 业绩预告情况 1、2025年年度预计业绩情况 扭亏为盈 √ 同向上升 同向下降 | 项 | 目 | | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | 盈利： 14500 万元 – | | 15200 | 万元 | 盈利：11402.48 | 万元 | | | | 比上年同期增长：27.17%-33.30% | | | | | | | 扣除非经常性损 | | 盈利： 14100 万元 – | | 14800 | 万元 | 盈利：10323.08 | 万元 | | 益后的净利润 | | 比上年同期增长：36.59%-43.37% | | | ...

Group 1 - The chemical fiber sector experienced a slight increase of 0.11% on January 7, with Jilin Carbon Valley leading the gains [1] - The Shanghai Composite Index closed at 4085.77, up 0.05%, while the Shenzhen Component Index closed at 14030.56, up 0.06% [1] - Notable gainers in the chemical fiber sector included Jilin Qigu, which rose by 5.63% to a closing price of 18.02, and Taihe New Materials, which increased by 4.46% to 11.71 [1] Group 2 - The chemical fiber sector saw a net outflow of 214 million yuan from main funds, while retail funds had a net inflow of 25.27 million yuan [2] - The trading volume for Jilin Qigu was 281,000 shares, with a transaction value of 497 million yuan, indicating strong investor interest [1][2] - The overall market sentiment reflected mixed performances, with some stocks like Sanfangxiang and Haiyang Technology experiencing declines of 6.20% and 4.10%, respectively [2] Group 3 - Main fund inflows were observed in stocks like Xinxiang Chemical Fiber, which had a net inflow of 36.42 million yuan, and Nanjing Chemical Fiber with 16.69 million yuan [3] - Retail investors showed a negative sentiment towards several stocks, with significant outflows from Xinxiang Chemical Fiber and Nanjing Chemical Fiber, indicating potential concerns among smaller investors [3] - The overall trading dynamics suggest a cautious approach among investors, with main funds favoring certain stocks while retail investors exhibited mixed reactions [3]